ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid

Adjuvant endocrine therapy (AET) is the treatment of choice for early-stage estrogen receptor alpha (ERα)-positive breast cancer (BC). However, almost 40% of tamoxifen-treated cases display no response or a partial response to AET, thus increasing the need for new treatment options and strong predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Meligova, Aggeliki K., Siakouli, Dimitra, Stasinopoulou, Sotiria, Xenopoulou, Despoina S., Zoumpouli, Maria, Ganou, Vassiliki, Gkotsi, Eleni-Fani, Chatziioannou, Aristotelis, Papadodima, Olga, Pilalis, Eleftherios, Alexis, Michael N., Mitsiou, Dimitra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959521/
https://www.ncbi.nlm.nih.gov/pubmed/36835157
http://dx.doi.org/10.3390/ijms24043747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959521/
https://www.ncbi.nlm.nih.gov/pubmed/36835157
http://dx.doi.org/10.3390/ijms24043747

Ejemplares similares